- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT04979559
Mobile Health Application of Screening and Early Intervention for Prediabetic Patient at Primary Health Cares Setting
Development Mobile Health Application of Screening and Early Intervention for Prediabetic Patient at Primary Health Cares Setting: Protocol of a Pilot Study
Background: Preventing type-2 diabetes mellitus begins with early screening and intervention of prediabetic participants. Until now, prediabetes screening and early intervention have not been optimal. The rapid advancement of technology, as well as its increased use, may provide an opportunity to improve the quality and cost of healthcare services. It is quite practicable to investigate and implement a valid, practical and easy-to-use mobile health application for participants and health staffs in screening and early intervention of prediabetes participants at primary health cares setting. This protocol aimed to identify and develop a valid, practical, and easy-to-use mobile health application for screening and early intervention of prediabetes participants at primary health cares.
Methods: This protocol was prepared in accordance with the Standard Protocol Items: Recommendations for Interventional Trials 2013 statement. This is a mixed-methods study with sequential exploratory approach. This project will begin with in-depth interview to gather qualitative information regarding mobile health application necessity for prediabetes participants at the primary health cares. The impact of the usage will be studied quantitatively using randomized controlled trial. Prediabetic participants and primary health cares staffs at Yogyakarta province will be the research subjects. The collected findings will be examined based on the type of the data.
Discussion: The proposed research aimed to obtain information and trial results regarding mobile health application usage for prediabetes participants screening and early intervention at primary health cares setting.
Przegląd badań
Status
Interwencja / Leczenie
Szczegółowy opis
The goal of this study is to create a mobile health application for prediabetes patients that included screening and early intervention in Primary Health Cares (PHCs) setting. More specifically, the objectives are as follows:
- To portray regular prediabetes screening and early intervention practice in PHCs.
- To assess prediabetes screening and early intervention data necessity for mobile health application model at PHCs.
- To assess the feasibility of mobile health application usage for screening and early intervention of prediabetes patients at PHCs.
- To assess internal and external factors that influence the intention-to-use, easiness, and usefulness of mobile health applications for prediabetes patients and health staff.
- To assess the impact of early intervention using mobile health applications on prediabetes patients.
Typ studiów
Zapisy (Oczekiwany)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Kontakt w sprawie studiów
- Nazwa: Yaltafit A Jeem
- Numer telefonu: +62 856-4366-1294
- E-mail: yaltafit.abror.j@ugm.ac.id
Kopia zapasowa kontaktu do badania
- Nazwa: Russy N Andriani
- Numer telefonu: +6287821562151
- E-mail: russy.novita@gmail.com
Lokalizacje studiów
-
-
Yogyakarta
-
Sleman, Yogyakarta, Indonezja, 55571
- Rekrutacyjny
- Kalasan PHC
-
Kontakt:
- Yaltafit A Jeem
- Numer telefonu: +62 856-4366-1294
- E-mail: yaltafit.abror.j@ugm.ac.id
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- diagnosed as the prediabetic state using American Diabetes Association (ADA) criteria
- have no previous diagnosis of type 2 diabetes or history of taking anti-hyperglycemic drugs
- have access to and able to use a personal smartphone
- willing to undertake study activities and written informed consent
Exclusion Criteria:
- severe medical condition
- disability to perform physical activity
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Ekranizacja
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Podwójnie
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Eksperymentalny: mHealth apps
The participants in this arm will receive information regarding mobile health applications used for screening and early intervention of the prediabetic states.
|
Mobile health application intervention including screening and early intervention such as diet and physical activity suggestion
|
Aktywny komparator: Standard care
The participant in this arm will receive regular practice or standard care of screening and early intervention of prediabetic state.
|
Regular practice for screening and early intervention for prediabetes patient in primary health cares setting
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Body weight mean change from baseline
Ramy czasowe: at baseline and after intervention at 12-weeks
|
Participants' body weight measured by scales using kilograms (kg) measurement unit
|
at baseline and after intervention at 12-weeks
|
Waist circumference mean change from baseline
Ramy czasowe: at baseline and after intervention at 12-weeks
|
Participants' waist circumference measured using measuring tape in centimeter (cm) measurement unit
|
at baseline and after intervention at 12-weeks
|
Fasting blood glucose mean change from baseline
Ramy czasowe: at baseline and after intervention at 12-weeks
|
Participants' fasting blood glucose measured from vein blood in milligram per deciliter (mg/dL) measurement unit
|
at baseline and after intervention at 12-weeks
|
Hemoglobin A1c mean change from baseline
Ramy czasowe: at baseline and after intervention at 12-weeks
|
Participants' Hemoglobin A1c measured from vein blood in percent
|
at baseline and after intervention at 12-weeks
|
Oral glucose tolerance test mean change from baseline
Ramy czasowe: at baseline and after intervention at 12-weeks
|
Participants' oral glucose tolerance test measured from vein blood in milligram per deciliter (mg/dL) measurement unit
|
at baseline and after intervention at 12-weeks
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Area under the curve of screening instrument compared to American Diabetes Association criteria
Ramy czasowe: immediately after the intervention begin
|
screening accuracy of the instrument reported using graph
|
immediately after the intervention begin
|
Sensitivity value of screening instrument compared to American Diabetes Association criteria
Ramy czasowe: immediately after the intervention begin
|
Sensitivity value of the instrument calculated using formula derived from 2x2 tables of diagnostic test
|
immediately after the intervention begin
|
Specificity value of screening instrument compared to American Diabetes Association criteria
Ramy czasowe: immediately after the intervention begin
|
Specificity value of the instrument calculated using formula derived from 2x2 tables of diagnostic test
|
immediately after the intervention begin
|
Positive predictive value of screening instrument compared to American Diabetes Association criteria
Ramy czasowe: immediately after the intervention begin
|
Positive predictive value of the instrument calculated using formula derived from 2x2 tables of diagnostic test
|
immediately after the intervention begin
|
Negative predictive value of screening instrument compared to American Diabetes Association criteria
Ramy czasowe: immediately after the intervention begin
|
Negative predictive value of the instrument calculated using formula derived from 2x2 tables of diagnostic test
|
immediately after the intervention begin
|
Accuracy value of screening instrument compared to American Diabetes Association criteria
Ramy czasowe: immediately after the intervention begin
|
Accuracy predictive value of the instrument calculated using formula derived from 2x2 tables of diagnostic test
|
immediately after the intervention begin
|
Likelihood ratio of screening instrument compared to American Diabetes Association criteria
Ramy czasowe: immediately after the intervention begin
|
Likelihood ratio of the instrument calculated using formula derived from 2x2 tables of diagnostic test
|
immediately after the intervention begin
|
Inne miary wyników
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Participant's acceptance of mobile health application
Ramy czasowe: after intervention at 12-weeks
|
evaluation of participant's acceptance to the device using Mobile Health Application Acceptance Questioner adapted from previous study
|
after intervention at 12-weeks
|
Współpracownicy i badacze
Sponsor
Współpracownicy
Śledczy
- Główny śledczy: Yaltafit A Jeem, Gadjah Mada University
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Oczekiwany)
Ukończenie studiów (Oczekiwany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- KE/FK/1375/EC/2020
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Mobile health apps
-
Boston UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... i inni współpracownicyRekrutacyjnyKarmienie piersią | SUID | SIDSStany Zjednoczone
-
University of EdinburghMaternal, Neonatal and Child Health Research NetworkZakończony
-
Hiroshima UniversityZakończony
-
University of MiamiNational Institute on Drug Abuse (NIDA)RekrutacyjnyHIV/AIDSStany Zjednoczone
-
Icahn School of Medicine at Mount SinaiApple Inc.; Sage Bionetworks; Lifemap Solutions, IncZakończony
-
NYU Langone HealthAgency for Healthcare Research and Quality (AHRQ)Jeszcze nie rekrutacjaCukrzyca typu 2Stany Zjednoczone
-
University of California, DavisStanford University; Rutgers University; Northeastern UniversityAktywny, nie rekrutujący
-
University of OttawaZakończony
-
Columbia UniversityUniversity of Alabama at Birmingham; National Institute on Minority Health and... i inni współpracownicyZakończonyZakażenia wirusem HIVStany Zjednoczone
-
Beijing Chao Yang HospitalPeking University; Guang'anmen Hospital of China Academy of Chinese Medical... i inni współpracownicyJeszcze nie rekrutacjaChoroby płuc, obturacyjne | Choroba płuc, przewlekła obturacja | POChP | Ostre zaostrzenie POChP | Wskaźnik readmisji | Mobilna Medycyna | Pielęgnacja pakietu | Telemedycyna mobilna